Search The Medical Knowledge Base
Medical News by Category
Immunodeficiency News
- FDA requires longer term trials for HyQvia (Halozyme/Baxter) for
Primary Immonodeficiency
Published: Wednesday 18 April 2012
- HyQ (Baxter)brand name to be HyQvia for Immunodeficiency
Published: Saturday 03 March 2012
- Baxter files subcutaneous HyQ at EMA for Primary Immune Deficiency
Published: Friday 30 September 2011